Healthcare >> CEO Interviews >> February 4, 2014
Alan W. Milinazzo is the President and CEO of InspireMD, Inc.; he has more than two and a half decades of executive management experience in the life sciences sector. He spent 12 years as an executive with Boston Scientific Corporation in numerous executive roles, including Vice President of Marketing for SCIMED Europe. Mr. Milinazzo then served as Vice President of Medtronic, Inc.’s Vascular business, as well as, Vice President and General Manager of Medtronic’s Coronary and Peripheral businesses. He was instrumental in the development and commercialization of a number of key products while at Medtronic, including the company’s first drug-coated stent platform, Endeavor, which has generated over $1 billion in revenues since its launch. Most recently, Mr. Milinazzo served at Orthofix International in 2005 as Chief Operating Officer and succeeded to the position of Chief Executive Officer in April of 2006. Mr. Milinazzo currently serves as a director of Flexion Therapeutics, Medpace and Tri-Medics, and holds a bachelor’s degree, cum laude, from Boston College. Profile
TWST: If you could, describe your background and what brought you to the company.
Mr. Milinazzo: I have spent 25 years in the medical device industry, about 15 years of that prior to